This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Illumina Cambridge Limited, Illumina Corporation, Illumina Singaore Pte Ltd. Active years: 2026.
Company Filing History:
1 out of 323 
1 out of 1,214 
1 out of 1 Years Active: 2026
Title: Pascale Mathonet: Innovator in Nucleic Acid Research
Introduction
Pascale Mathonet is an inventor based in Cambridge, GB. He is known for his contributions to the field of nucleic acid research. Although he currently holds no granted patents, his work is focused on innovative methods and applications in this area.
Latest Patent Applications
Mathonet's latest patent applications include "ALTERED CYTIDINE DEAMINASES AND METHODS OF USE." This application discusses proteins, methods, compositions, and kits for mapping the methylation status of nucleic acids, including 5-methylcytosine and 5-hydroxymethyl cytosine (5 hmC). The application describes proteins that selectively act on certain modified cytosines of target nucleic acids, converting them to thymidine or modified thymidine analogues. Another embodiment includes proteins that convert modified cytosines to uracil or thymidine while selectively not acting on other modified cytosines. Additionally, the application provides compositions and kits that incorporate these proteins and methods for their use.
Another significant application is for "SCAFFOLD PEPTIDES." This application presents a naive WW domain peptide library derived from a WW domain peptide sequence, diversified by altering the amino acid sequence at various positions. The methods for creating this peptide library and selecting modified WW domain peptides that bind target ligands are also detailed. Furthermore, the application discusses modified WW domain peptides with improved binding characteristics compared to their unmodified counterparts, along with pharmaceutical compositions and uses for these peptides.
Conclusion
Pascale Mathonet is an innovative inventor whose work in nucleic acid research holds promise for future advancements in the field. His latest patent applications reflect a commitment to developing new methods and compositions that could significantly impact scientific research and applications.